TY - JOUR T1 - Evaluation and Selection of Quality Indicators for the Management of Endometrial Cancer JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 979 LP - 986 DO - 10.1097/IGC.0000000000000980 VL - 27 IS - 5 AU - Laure Chenoz AU - Juliette Phelippeau AU - Emmanuel Barranger AU - Nicolas Bourdel AU - Jean Luc Brun AU - Elisabeth Chereau AU - Pierre Collinet AU - Charles Coutant AU - Emile Darai AU - Xavier Deffieux AU - Tristan Gautier AU - François Golfier AU - Cyrille Huchon AU - Lobna Ouldamer AU - Roman Rouzier AU - Martin Koskas Y1 - 2017/06/01 UR - http://ijgc.bmj.com/content/27/5/979.abstract N2 - Objective The aim of this study was to evaluate 36 quality indicators (QIs) for monitoring the quality of care of uterine cancer to be implemented in the EFFECT (effectiveness of endometrial cancer treatment) project.Methods The 36 QIs were evaluated in the first 10 patients diagnosed with endometrial cancer and managed in 14 French hospitals in 2011. To assess the status of each QI, a questionnaire detailing the 36 QIs was sent to each hospital, and the information was cross-checked with information from the multidisciplinary staff meeting, surgical reports, and pathological reports. The QIs were evaluated in terms of measurability and improvability. The remaining QIs were evaluated with a multiple correspondence analysis to highlight the interrelationships between qualitative variables describing a population.Results Thirteen of the 14 institutions responded to the survey for a total of 130 patients. Twenty-five of the 36 QIs affected less than 80% of the patients. Thirteen QIs were found not to be improvable because they reached more than 95% of the theoretical target. Finally, 5 QIs concerning more than 80% of the patients were found to be improvable. The multiple correspondence analysis finally identified 3 dimensions—outcome, safety, and perioperative management—that included the 5 QIs.Conclusions In the present study, 5 of the 36 QIs suggested by the EFFECT project seem to be sufficient to report on the quality of endometrial cancer management. Further studies are needed to correlate the information provided by those 5 questions and the relevant outcomes reflecting quality of care in endometrial cancer. ER -